Portage Biotech Inc.
PRTG
$9.11
$0.252.82%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.88M | -1.88M | -1.36M | -1.66M | -24.89M |
| Total Depreciation and Amortization | 10.00K | 10.00K | 7.00K | 8.00K | 13.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 424.50K | 424.50K | -91.00K | -1.01M | 22.07M |
| Change in Net Operating Assets | 333.00K | 333.00K | -116.00K | 968.00K | -313.00K |
| Cash from Operations | -1.11M | -1.11M | -1.56M | -1.69M | -3.12M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 2.81M |
| Cash from Investing | -- | -- | -- | -- | 2.81M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -14.00K | -14.00K | -10.00K | -9.00K | -12.00K |
| Issuance of Common Stock | 1.08M | 1.08M | 0.00 | 1.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 8.00K |
| Cash from Financing | 1.06M | 1.06M | -10.00K | -8.00K | -4.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.00K | -47.00K | -1.57M | -1.69M | -313.00K |